Publicaciones (55) Publicaciones de JOSÉ MANUEL GARRIDO JIMÉNEZ

2025

  1. Impact of chronic renin-angiotensin-aldosterone inhibitors on short-term outcomes in patients with acute heart failure presenting to the emergency department. A propensity-matched analysis EAHFE cohort

    International Journal of Cardiology, Vol. 418

2024

  1. Association of intravenous digoxin use in acute heart failure with rapid atrial fibrillation and short-term mortality according to patient age, renal function, and serum potassium

    European Journal of Emergency Medicine, Vol. 31, Núm. 5, pp. 347-355

  2. Clinical features, management in the emergency department and mortality of acute heart failure episodes in patients with chronic obstructive pulmonary disease

    Revista Clinica Espanola

  3. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine, Vol. 127, pp. 126-133

  4. Effect of early initiation of noninvasive ventilation in patients transported by emergency medical service for acute heart failure

    European Journal of Emergency Medicine, Vol. 31, Núm. 5, pp. 339-346

  5. Effect of seasonal influenza and COVID-19 vaccination on severity and long-term outcomes of patients with heart failure decompensations

    European Journal of Heart Failure

  6. Endovascular Technique for Ascending Aorta Repair Based on TEVAR and TAVI Procedures

    Journal of Endovascular Therapy, Vol. 31, Núm. 3, pp. 360-365

  7. Mechanical circulatory support in cardiogenic shock patients

    Medicina Intensiva

  8. Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients

    Internal and Emergency Medicine, Vol. 19, Núm. 4, pp. 1089-1098

2023

  1. Cardiac resynchronization therapy in acute heart failure and left bundle-branch block in a real-life registry

    Colombia Medica, Vol. 54, Núm. 4

  2. Discovery of a synthetic taiwaniaquinoid with potent in vitro and in vivo antitumor activity against breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 168

  3. Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 227-237

  4. Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis

    Breast, Vol. 69, pp. 342-348

  5. Surgical complications in endovenous extraction of cardiac electrostimulation device infections

    Cirugia Cardiovascular, Vol. 30, Núm. 4, pp. 195-202

  6. Temporal ordering criteria for surgical interventions in cardiovascular and endovascular pathology. 2022 version

    Cirugia Cardiovascular, Vol. 30, Núm. 1, pp. 24-33

  7. Valve repair in mitral endocarditis

    Cirugia Cardiovascular, Vol. 30, pp. S28-S33

2022

  1. Mathematical model optimized for prediction and health care planning for COVID-19

    Medicina Intensiva, Vol. 46, Núm. 5, pp. 248-258

  2. Nuevas evidencias sobre seguridad de los ECMO cebados por periodos superiores a los recomendados por los fabricantes [resumen]

    Revista Española de Perfusión, Núm. 72, pp. 21

  3. Surgical management of tricuspid regurgitation: a new algorithm to minimise recurrent tricuspid regurgitation

    Open Heart, Vol. 9, Núm. 2

2021

  1. Impact of COVID-19 on the cardiovascular surgery departments in Spain: Analysis of the diagnostic-related groups (SECCE-COVID-19 Study phase 2)

    Cirugia Cardiovascular, Vol. 28, Núm. 4, pp. 194-198